Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
AIDS ; 26(15): 1869-78, 2012 Sep 24.
Article in English | MEDLINE | ID: mdl-22874514

ABSTRACT

OBJECTIVE: Both protective T-cell genotypes and natural killer (NK) cell genotypes have been associated with delayed progression to AIDS and shown to be co-inherited in HIV-1-infected individuals who limit viral replication in absence of antiretroviral therapy ('controllers'). However, a comparative analysis of the genotype and function of the innate and adaptive immune compartments in HIV-1-infected controller individuals has been understudied to date. DESIGN: Here, we simultaneously tested NK and T-cell function in controllers to investigate the mechanism(s) that might account for host immune control over viral replication. METHODS: We measured CD8 T-cell responses against HIV-1 utilizing overlapping 15-mer peptides spanning the HIV-1 consensus clade B Gag protein and tested NK cell degranulation and cytokine secretion against tumor target cells following interferon-α (IFNα) stimulation. RESULTS: Among a cohort of 37 controllers, the presence of protective major histocompatibility complex class I human leukocyte antigen (HLA) alleles (such as HLA-B*57) was not correlated with HIV-specific CD8 responses. In contrast, the inheritance of a protective killer inhibitory receptor KIR3DL1*h/*y receptor genotype along with the corresponding HLA-Bw4*80I ligand was associated with significantly heightened target cell-induced NK degranulation and cytokine secretion following IFNα stimulation (P = 0.0201, n = 13). Interestingly, we observed a significant inverse association between the IFNα stimulated NK response to K562 cells and the HIV-specific CD8 T-cell response to Gag among elite controllers (rho = -0.8321, P = 0.0010, n = 12). CONCLUSION: Together, these results suggest that heightened NK responses can be evidenced independently of HIV-specific T-cell responses in HIV-1-infected elite controllers.


Subject(s)
Acquired Immunodeficiency Syndrome/immunology , HIV Seropositivity/immunology , HIV-1/immunology , Killer Cells, Natural/immunology , Receptors, KIR3DL1/immunology , Receptors, KIR/immunology , Acquired Immunodeficiency Syndrome/metabolism , Acquired Immunodeficiency Syndrome/physiopathology , Adaptive Immunity , Adult , CD4-Positive T-Lymphocytes/immunology , CD8-Positive T-Lymphocytes/immunology , California , Disease Progression , Female , Genotype , HIV Seropositivity/metabolism , HIV Seropositivity/physiopathology , Humans , Immunity, Innate , Male , RNA, Viral , Receptors, KIR3DL1/genetics , Receptors, KIR3DL1/metabolism , Virus Replication/immunology
SELECTION OF CITATIONS
SEARCH DETAIL
...